HLA class II susceptibility and resistance genes in patients with multiple sclerosis from northern Spain, by DNA-RFLP genotyping.
作者信息
Uría D F, Gutierrez V, Menes B B, Arribas J M, Lopez-Larrea C
出版信息
J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):722-3. doi: 10.1136/jnnp.56.6.722.
Abstract
摘要
相似文献
1
HLA class II susceptibility and resistance genes in patients with multiple sclerosis from northern Spain, by DNA-RFLP genotyping.西班牙北部多发性硬化症患者中 HLA Ⅱ类易感基因和抗性基因的 DNA-RFLP 基因分型研究
J Neurol Neurosurg Psychiatry. 1993 Jun;56(6):722-3. doi: 10.1136/jnnp.56.6.722.
2
The HLA-D region-associated MS-susceptibility genes may be located telomeric to the HLA-DP subregion.
Tissue Antigens. 1990 Jul;36(1):37-9. doi: 10.1111/j.1399-0039.1990.tb01796.x.
3
Rapid and practical HLA class II genotyping by reverse dot blotting.通过反向斑点杂交进行快速实用的HLA II类基因分型
Transplant Proc. 1993 Feb;25(1 Pt 1):194-8.
4
DNA polymorphism of the class II genes in DR4 cells.
Dis Markers. 1986 Jun;4(1-2):165-72.
5
[Class II HLA typing based on the restriction fragment length polymorphisms of DNA].基于DNA限制性片段长度多态性的II类人类白细胞抗原分型
Rev Fr Transfus Hemobiol. 1990 Jun;33(3):175-201. doi: 10.1016/s1140-4639(05)80192-3.
6
HLA-D region RFLP and type 1 diabetes.HLA - D区域限制性片段长度多态性与1型糖尿病
Diabet Med. 1988 Sep;5(6):596-7. doi: 10.1111/j.1464-5491.1988.tb01060.x.
7
Determination of RFLPs linked to multiple sclerosis susceptibility.与多发性硬化易感性相关的限制性片段长度多态性的测定。
Ann N Y Acad Sci. 1988;540:269-70. doi: 10.1111/j.1749-6632.1988.tb27073.x.
8
HLA class II RFLPs are haplotype-specific.人类白细胞抗原（HLA）Ⅱ类限制性片段长度多态性（RFLPs）具有单倍型特异性。
Cold Spring Harb Symp Quant Biol. 1986;51 Pt 1:83-9. doi: 10.1101/sqb.1986.051.01.011.
9
HLA associations in multiple sclerosis: implications for immunopathogenesis.多发性硬化症中的HLA关联：对免疫发病机制的影响。
Res Immunol. 1989 Feb;140(2):192-6; discussion 245-8. doi: 10.1016/0923-2494(89)90085-0.
10
HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.多发性硬化症中的人类白细胞抗原-DRβ、-DQα和-DQβ限制性片段长度多态性
J Neurosci Res. 1989 May;23(1):46-54. doi: 10.1002/jnr.490230107.
引用本文的文献
1
HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).西班牙巴斯克地区比斯开省多发性硬化症患者的 HLA Ⅱ类等位基因。
J Neurol. 2009 Dec;256(12):1977-88. doi: 10.1007/s00415-009-5223-2.
2
Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice.HLA-DRB1*0401 限制性 MBP 111-129 特异性人源化 TCR 转基因小鼠的独特临床和病理特征。
J Exp Med. 2004 Jul 19;200(2):223-34. doi: 10.1084/jem.20030994.
3
Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire.在HLA - DR4（B1*0401）受试者中，低亲和力的主要组织相容性复合体结合髓鞘碱性蛋白表位（第111 - 129位氨基酸残基）的免疫显性与受限的T细胞受体库相关。
J Clin Invest. 1997 Jul 15;100(2):339-49. doi: 10.1172/JCI119539.
本文引用的文献
1
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.多发性硬化症的新诊断标准：研究方案指南。
Ann Neurol. 1983 Mar;13(3):227-31. doi: 10.1002/ana.410130302.
2
DNA-RFLP analysis and genotyping of HLA-DR and DQ antigens.DNA-RFLP分析以及HLA-DR和DQ抗原的基因分型。
Immunol Today. 1988 Jan;9(1):18-23. doi: 10.1016/0167-5699(88)91351-5.
3
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities.主要为慢性进行性和复发/缓解型多发性硬化症：两种免疫遗传学上不同的疾病实体。
Proc Natl Acad Sci U S A. 1989 Sep;86(18):7113-7. doi: 10.1073/pnas.86.18.7113.
4
DNA analysis of HLA-DR4B1 subtypes in multiple sclerosis by specific oligonucleotide probes.使用特异性寡核苷酸探针分析多发性硬化症中HLA-DR4B1亚型的DNA
J Neuroimmunol. 1991 Jun;32(3):279-83. doi: 10.1016/0165-5728(91)90198-g.
5
Multiple sclerosis and HLA class II susceptibility and resistance genes.
J Neurosci Res. 1990 May;26(1):66-73. doi: 10.1002/jnr.490260108.
Zotero 插件